Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

MAIA Biotechnology Inc. (MAIA)

  • Company Report
  • Feb. 21, 2023, 21:37 UTC
  • 86
  • 0 comments

Noble Capital Markets Initiates Coverage on MAIA!

Comment Full text

QuantumSi Inc (QSI)

  • Company Report
  • Feb. 17, 2023, 16:04 UTC
  • 87
  • 0 comments

Quantum-Si to Participate in the 43rd Annual Cowen Health Care Conference

Comment Full text

Karyopharm Therapeutics Inc (KPTI)

  • Company Report
  • Feb. 17, 2023, 15:54 UTC
  • 88
  • 0 comments

New SEC Filing for Karyopharm Therapeutics Inc. (NASDAQ:KPTI)

Comment Full text

Ultragenyx Pharmaceutical Inc (RARE)

  • Company Report
  • Feb. 17, 2023, 14:20 UTC
  • 91
  • 0 comments

New Form 10-K for Ultragenyx Pharmaceutical Inc.

Comment Full text

Bio-Rad Laboratories Inc. (BIO)

  • Company Report
  • Feb. 17, 2023, 00:10 UTC
  • 86
  • 0 comments

Bio-Rad - Fourth Quarter 2022

Comment Full text

Citius Pharmaceuticals Inc. (CTXR)

  • Company Report
  • Feb. 16, 2023, 21:09 UTC
  • 90
  • 0 comments

Citius Pharmaceuticals, Inc. - First Quarter 2023

Comment Full text

MAIA Biotechnology Inc. (MAIA)

  • Company Report
  • Feb. 16, 2023, 19:52 UTC
  • 84
  • 0 comments

What We Fight at MAIA - Liver Cancer

Comment Full text

Sage Therapeutics Inc (SAGE)

  • Company Report
  • Feb. 16, 2023, 16:16 UTC
  • 84
  • 0 comments

New Form 10-K for Sage Therapeutics Inc

Comment Full text

Ironwood Pharmaceuticals Inc (IRWD)

  • Company Report
  • Feb. 16, 2023, 16:16 UTC
  • 86
  • 0 comments

Ironwood - Fourth Quarter 2022

Comment Full text

Seagen Inc (SGEN)

  • Company Report
  • Feb. 16, 2023, 00:05 UTC
  • 91
  • 0 comments

Seagen - Fourth Quarter 2022

Comment Full text
  • Previous
  • 28
  • 29
  • 30
  • 31
  • 32
  • Next

Search

News categories

  • Technical Exchange News(10298)
  • Event(1441)
  • SEC News(174913)
  • FDA Approval(9639)
  • Company Report(721)
  • Business News(117423)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin